Pharmacological properties of the isopropyl ester of o-sulfamoyl-benzoic acid.
D000818:Animals; D001522:Behavior, Animal / Q000187:drug effects*; D001565:Benzoates / Q000494:pharmacology*; D002219:Carbamates / Q000494:pharmacology; D002328:Carisoprodol / Q000494:pharmacology; D002707:Chlordiazepoxide / Q000494:pharmacology; D002720:Chlormezanone / Q000494:pharmacology; D002753:Chlorzoxazone / Q000494:pharmacology; D004285:Dogs; D004336:Drug Antagonism; D004597:Electroshock; D008297:Male; D008615:Mephenesin / Q000494:pharmacology; D008620:Meprobamate / Q000494:pharmacology; D008721:Methocarbamol / Q000494:pharmacology; D051379:Mice; D009132:Muscles / Q000494:pharmacology*; D010424:Pentobarbital / Q000494:pharmacology; D010627:Phenethylamines / Q000494:pharmacology; D010634:Phenobarbital / Q000494:pharmacology; D010672:Phenytoin / Q000494:pharmacology; D051381:Rats; D012018:Reflex / Q000187:drug effects*; D012640:Seizures / Q000139:chemically induced; D012890:Sleep / Q000187:drug effects*; D013331:Strychnine / Q000494:pharmacology; D014293:Trimethadione / Q000494:pharmacology; D015049:Zoxazolamine / Q000494:pharmacology
D001565:Benzoates; D002219:Carbamates; D010627:Phenethylamines; D008721:Methocarbamol; D002328:Carisoprodol; D010672:Phenytoin; D002707:Chlordiazepoxide; D008615:Mephenesin; D015049:Zoxazolamine; D008620:Meprobamate; D002720:Chlormezanone; D002753:Chlorzoxazone; D013331:Strychnine; D010424:Pentobarbital; D014293:Trimethadione; D010634:Phenobarbital